Bluejay Diagnostics
Acton
About Bluejay Diagnostics
Bluejay Diagnostics, Inc. develops, manufactures and markets easy-to-use, point-of-care medical diagnostics tests. The company offers multiple FDA-Cleared non-invasive, affordable products, including the Allereye® Tear Total IgE Test used to aid in the diagnosis of allergic conjunctivitis, and a urine-based HIV-1 screening test and a HIV-1 confirmatory test. Bluejay, headquartered in Acton, Massachusetts, continues to leverage its innovate, proprietary platform to develop new products for underserved diagnostic markets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $24.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:BJDX
- Website: bluejaydx.com
- Phone: 978.631.4884
Industries & Categories
Manufacturing, Marketing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/bluejay-diagnostics-99459 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.